Literature DB >> 6166248

Combined antiviral effect of interferon and acyclovir on herpes simplex virus types 1 and 2.

T L Stanwick, R F Schinazi, D E Campbell, A J Nahmias.   

Abstract

Acyclovir and human interferon displayed an additive to synergistic effect in reducing the number of herpes simplex viral plaque-forming units in Vero cells, suggesting a therapeutic potential for such combination therapy.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6166248      PMCID： PMC181499          DOI： 10.1128/AAC.19.4.672

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

Review 1.  Clinical trials with exogenous interferon: summary of a meeting.

Authors:  J K Dunnick; G J Galasso
Journal:  J Infect Dis       Date:  1979-01       Impact factor: 5.226

2.  Inhibition of Herpesvirus hominis replication by human interferon.

Authors:  L Rasmussen; L B Farley
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

3.  Effect of 9-(2-hydroxyethoxymethyl)guanine on herpesvirus-induced keratitis and iritis in rabbits.

Authors:  H E Kaufman; E D Varnell; Y M Centifanto; S D Rheinstrom
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

4.  Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.

Authors:  P M Ejercito; E D Kieff; B Roizman
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

5.  Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine.

Authors:  R J Klein; A E Friedman-Kien; E DeStefano
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

6.  Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root.

Authors:  G J Pazin; J A Armstrong; M T Lam; G C Tarr; P J Jannetta; M Ho
Journal:  N Engl J Med       Date:  1979-08-02       Impact factor: 91.245

7.  Efficacy of acycloguanosine (Wellcome 248U) against herpes-simplex corneal ulcers.

Authors:  B R Jones; D J Coster; P N Fison; G M Thompson; L M Cobo; M G Falcon
Journal:  Lancet       Date:  1979-02-03       Impact factor: 79.321

8.  Differential sensitivity of herpes simplex virus types 1 and 2 to human interferon: antiviral effects of interferon plus 9-beta-D-arabinofuranosyladenine.

Authors:  A M Lerner; E J Bailey
Journal:  J Infect Dis       Date:  1976-10       Impact factor: 5.226

9.  Combined antiviral effects of interferon, adenine, arabinoside, hypoxanthine arabinoside, and adenine arabinoside-5'-monophosphate in human fibroblast cultures.

Authors:  Y J Bryson; L H Kronenberg
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

10.  Effect of acycloguanosine treatment of acute and latent herpes simplex infections in mice.

Authors:  H J Field; S E Bell; G B Elion; A A Nash; P Wildy
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191
View more
  27 in total

1.  Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet.

Authors:  R Koshida; L Vrang; G Gilljam; J Harmenberg; B Oberg; B Wahren
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

2.  Potentiation by levamisole, methisoprinol, and adenine or adenosine of the inhibitory activity of human interferon against encephalomyocarditis virus.

Authors:  A Muñoz; R A García; A Pérez-Aranda
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

3.  Biosynthetic human interferon treatment of herpetic keratitis.

Authors:  G Smolin
Journal:  Trans Am Ophthalmol Soc       Date:  1983

4.  Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice.

Authors:  R F Schinazi; J Peters; C C Williams; D Chance; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

5.  Synergistic antiviral effects of antiherpes compounds and human leukocyte interferon on varicella-zoster virus in vitro.

Authors:  M Baba; M Ito; S Shigeta; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

6.  Synergistic therapy by acyclovir and A1110U for mice orofacially infected with herpes simplex viruses.

Authors:  M N Ellis; D C Lobe; T Spector
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

7.  Acyclovir monotherapy versus acyclovir plus beta-interferon in focal viral encephalitis in children.

Authors:  U Wintergerst; B H Belohradsky
Journal:  Infection       Date:  1992 Jul-Aug       Impact factor: 3.553

8.  Comparative activities of selected combinations of acyclovir, vidarabine, arabinosyl hypoxanthine, interferon, and polyriboinosinic acid-polyribocytidylic acid complex against herpes simplex virus type 2 in tissue culture and intravaginally inoculated mice.

Authors:  L R Crane; D A Milne; J C Sunstrum; A M Lerner
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

9.  Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds.

Authors:  K O Smith; K S Galloway; K K Ogilvie; U O Cheriyan
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

10.  Enhanced efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine in combination with beta-interferon against herpes simplex virus type 2 in mice.

Authors:  E B Fraser-Smith; D A Eppstein; Y V Marsh; T R Matthews
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.